p.7 抽出テキスト

............................................................................................................................................................................ DPP-4 Dipeptidyl peptidase-4 DSC2 Desmocollin 2 DSG2 Desmoglein 2 DSP Desmoplakin DT Destination therapy E/e0 (ratio) E/e0 (ratio) = early filling velocity on transmitral Doppler/early relaxation velocity on tissue Doppler EACVI European Association of Cardiovascular Imaging (part of the European Society of Cardiology) EAST-AFNET 4 Early Treatment of Atrial Fibrillation for Stroke Prevention Trial 4 (trial) ECG Electrocardiogram EchoCRT Echocardiography Guided Cardiac Resynchronization Therapy (trial) ECLS Extracorporeal life support ECMO Extracorporeal membrane oxygenation EF Ejection fraction eGFR Estimated glomerular filtration rate EHRA European Heart Rhythm Association EMA European Medicines Agency EMB Endomyocardial biopsy EMPA-REG OUTCOME

Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (trial) EMPEROR- Reduced

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (trial) EROA Effective regurgitant orifice area ESC European Society of Cardiology EU European Union EuroSCORE II European System for Cardiac Operative Risk Evaluation II (score) FDA Food and Drug Administration FDG Fluorodeoxyglucose FiO2 Fraction of inspired oxygen FLN Filamin FLNC Filamin C GGT Gamma-glutamyl transferase GISSI-HF Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico  Heart Failure (trial) GLP-1 Glucagon-like peptide-1 GUIDE-HF Hemodynamic-GUIDEd Management of Heart Failure (trial) h Hour/hours H2FPEF Heavy (BMI>30 kg/m2), Hypertensive (use of >_2 antihypertensive medications), atrial Fibrillation (paroxysmal or persistent), Pulmonary hypertension (Doppler Echocardiographic estimated Pulmonary Artery Systolic Pressure >35 mmHg), Elderly (age >60 years), Filling pressure (Doppler Echocardiographic E/e0 >9) (score) HbA1c Glycated haemoglobin HCM Hypertrophic cardiomyopathy HEART Heart Failure Revascularisation Trial HER2 Human epidermal growth factor receptor 2 HF Heart failure HFA Heart Failure Association HFA-PEFF Heart Failure Association of ESC diagnostic algorithm, P  Initial Workup (Step 1: Pretest Assessment), E - Diagnostic Workup (Step 2: Echocardiographic and Natriuretic Peptide score), F1  Advanced Workup (Step 3: Functional testing in Case of Uncertainty), F2  Aetiological Workup (Step 4: Final Aetiology) HF-MP Heart failure management programme HFmrEF Heart failure with mildly reduced ejection fraction HFpEF Heart failure with preserved ejection fraction HFrEF Heart failure with reduced ejection fraction HHV Human herpes virus HIV Human immunodeficiency virus HLA-DR Human leukocyte antigen-DR isotype HMDP Hydroxyl-methylene-diphosphonate HR Hazard ratio HT Heart transplantation HTM Home telemonitoring i.v. Intravenous IABP Intra-aortic balloon pump ICCU Intensive coronary care unit ICD Implantable cardioverter-defibrillator ICU Intensive care unit IHD Ischaemic heart disease INR International normalized ratio INTERMACS Interagency Registry for Mechanically Assisted Circulatory Support INTrEPID Investigation of Nontransplant-Eligible Patients Who Are Inotrope Dependent (trial) IOCM Iron overload cardiomyopathy IPD Individual patient data I-PRESERVE Irbesartan in Patients with Heart Failure and PRESERVEd Ejection Fraction (trial) KCNH2 Potassium voltage-gated channel subfamily H member 2 KCNQ1 Potassium voltage-gated channel subfamily Q member 1 LA Left atrium/atrial LAE Left atrial enlargement LBBB Left bundle branch block LDB3 LIM domain binding 3 LFT Liver function test LGE Late gadolinium enhancement LMNA Lamin A/C LMWH Low-molecular-weight heparin LUS Lung ultrasound LV Left ventricular/ventricle LVAD Left ventricular assist device Downloaded from academic.oup.com/eurheartj/article/42/36/3599/6358045 by guest on 07 October 2026